Diaz Maureen H, Winchell Jonas M
Pneumonia Response and Surveillance Laboratory, Respiratory Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta GA, USA.
Front Microbiol. 2016 Mar 8;7:232. doi: 10.3389/fmicb.2016.00232. eCollection 2016.
Over the past decade there have been significant advancements in the methods used for detecting and characterizing Mycoplasma pneumoniae, a common cause of respiratory illness and community-acquired pneumonia worldwide. The repertoire of available molecular diagnostics has greatly expanded from nucleic acid amplification techniques (NAATs) that encompass a variety of chemistries used for detection, to more sophisticated characterizing methods such as multi-locus variable-number tandem-repeat analysis (MLVA), Multi-locus sequence typing (MLST), matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS), single nucleotide polymorphism typing, and numerous macrolide susceptibility profiling methods, among others. These many molecular-based approaches have been developed and employed to continually increase the level of discrimination and characterization in order to better understand the epidemiology and biology of M. pneumoniae. This review will summarize recent molecular techniques and procedures and lend perspective to how each has enhanced the current understanding of this organism and will emphasize how Next Generation Sequencing may serve as a resource for researchers to gain a more comprehensive understanding of the genomic complexities of this insidious pathogen.
在过去十年中,用于检测和鉴定肺炎支原体的方法取得了重大进展。肺炎支原体是全球呼吸道疾病和社区获得性肺炎的常见病因。可用的分子诊断方法已大幅扩展,从包含多种检测化学方法的核酸扩增技术(NAATs),到更复杂的鉴定方法,如多位点可变数目串联重复分析(MLVA)、多位点序列分型(MLST)、基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)、单核苷酸多态性分型,以及众多大环内酯类药物敏感性分析方法等。这些基于分子的方法不断发展和应用,以持续提高鉴别和鉴定水平,从而更好地了解肺炎支原体的流行病学和生物学特性。本综述将总结近期的分子技术和程序,并阐述每种技术如何增进了我们目前对该病原体的认识,同时将强调下一代测序技术如何为研究人员提供资源,以更全面地了解这种隐匿性病原体的基因组复杂性。